Anti- Pseudomonas Fluorescens antibodies (Anti-PF)ELISA KIT
Size
one plate of 96 wells per kit
Species reactivity
Human (Homo sapiens)
Product type
Immunoassays, ELISA kits
Recognized antigen
Anti- Pseudomonas Fluorescens antibodies (Anti-PF)
Test
ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED
Long Name
Human Anti- Pseudomonas Fluorescens antibodies (Anti-PF)ELISA KIT
Properties
E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays
Additional description
This antibody needs to be stored at + 4°C in a fridge short term in a concentrated dilution. Freeze thaw will destroy a percentage in every cycle and should be avoided.Antibody for research use.
Laboratory tips
Small volumes from the liquid components of the Anti- Pseudomonas Fluorescens antibodies (Anti-PF)EIA kit may get caught on the walls and lid of the vials. Prior to use, briefly centrifuge the vial to ensure that all of the content is gathered on the bottom.
About
Pseudomonas is a Gram-negative bacteria. Pseudomonas genomic sequences are used in medical research. A problem in hostpital is often the Pseudomonas Aeruginosa containing multi drug resistancy properties that are transmitted through plasmids. The MDR property is transmitter by the R plasmid.
Description
The Human Anti- Pseudomonas Fluorescens antibodies (Anti-PF)ELISA KIT is a ready to use kit manufactured by using high quality antibodies sets, plates, solutions and detection molecules. This EIA test for Human Anti- Pseudomonas Fluorescens antibodies (Anti-PF) will yield accurate and reproducible results. The specially designed buffers ensure the most suitable conditions for the detection reactions.
Storage conditions
Store all components and reagents of the Anti- Pseudomonas Fluorescens antibodies (Anti-PF)ELISA KIT refrigerated and +4 degrees Celcius. For a long term storage the kit's components may be frozen at -20 but cycles of freezing and thawing should be strictly avoided as they denaturate the polypeptide chains in the antibodies and controlls, thus causing a reduction in the kit's detection ability and specificity which changes will lead to inconsistant results.
